Insulin decreases atherosclerosis by inducing endothelin receptor B expression
Kyoungmin Park(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Ditte Sørensen(Joslin Diabetes Center), Sayaka Katagiri(Joslin Diabetes Center), Paul L. Huang(Massachusetts General Hospital), I‐Hsien Wu(Joslin Diabetes Center), Akira Mima(Osaka University of Pharmaceutical Sciences), Yasutaka Maeda(Kyushu University), Pingnian He(Shihezi University), Christian Rask‐Madsen(University of Ulsan), Koji Mizutani(Nagoya University), Ernesto Maddaloni(Oxford Centre for Diabetes, Endocrinology and Metabolism), Qian Li(Sun Yat-sen University), Lars Melholt Rasmussen(University of Southern Denmark), Mogher Khamaisi, Simone Rørdam Preil(University of Southern Denmark)
Cited by 57
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979